by palligoelme@gmail.com | Oct 14, 2026 | Clinical Trials
Conditions: HLA/AAV Sensitization; Auto-immune Diseases; Hematologic Cancers Interventions: Genetic: LV009 Sponsors: Healthy Malaysia Association Not yet recruiting Conditions: HLA/AAV Sensitization; Auto-immune Diseases; Hematologic Cancers Interventions: Genetic:...
by palligoelme@gmail.com | Oct 14, 2026 | Clinical Trials
Conditions: Sleep Duration; Athletic Performance Interventions: Behavioral: Usual Morning Training Schedule; Behavioral: Delayed Morning Training Schedule Sponsors: Capital University of Physical Education and Sports, China Not yet recruiting Conditions: Sleep...
by palligoelme@gmail.com | Oct 14, 2026 | Clinical Trials
Conditions: Edentulism; All-on-4; Masticatory Efficiency; Dynamic Postural Balance Interventions: Device: All-on-4 Fixed Implant-Supported Prosthetic Rehabilitation Sponsors: Beni-Suef University Completed Conditions: Edentulism; All-on-4; Masticatory Efficiency;...
by palligoelme@gmail.com | Oct 14, 2026 | Clinical Trials
Conditions: Acute Myeloid Leukemia Interventions: Genetic: Bulk genotyping of AML samples at diagnosis and relapse, scRNA analysis at diagnosis, scRNAseq and genotyping analysis at day 28 after therapy, spatial transcriptomic analysis at day 0 and 28 Sponsors:...
by palligoelme@gmail.com | Oct 14, 2026 | Clinical Trials
Conditions: Paroxysmal Atrial Fibrillation; Pulsed Field Ablation; Catheter Ablation; Left Atrial Function; Cardiology Interventions: Device: Novel Pulsed Field Ablation System; Device: Radiofrequency Ablation Catheter Sponsors: Tianjin Medical University General...
by palligoelme@gmail.com | Oct 14, 2026 | Clinical Trials
Conditions: Thyroid Cancer; Tumor; Advanced Thyroid Carcinoma Interventions: Drug: Becotatug Vedotin (MRG003); Drug: Lenvatinib; Biological: Anti-PD-1 Inhibitor (Continuation of Prior Treatment) Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University...